News for Healthier Living

Professor Sarfaraz Niazi's Scientific Framework Adopted as FDA Modernizes Clinical Trial Evaluation Through Bayesian Methods

The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in clinical trials, formally recognizing Bayesian approaches that align with the long-standing scientific framework developed and advanced by Professor Sarfaraz K. Niazi, PhD, for evaluating drug and biosimilar efficacy without redundant clinical studies.

January 20, 2026


January 20 2026

January 19 2026

January 18 2026

January 17 2026

January 16 2026

January 15 2026

January 14 2026

January 13 2026

January 12 2026

January 11 2026

January 10 2026

January 9 2026

January 8 2026

January 7 2026

January 6 2026